Osteosarcoma is the most common malignant bone tumour, with a peak incidence in children and young adolescents, suggesting a role of rapid bone growth in its pathogenesis. The Wnt/β-catenin pathway plays a crucial role in skeletal development and is indispensable for osteoblasts' lineage determination. Previous studies suggesting an oncogenic role for the Wnt/β-catenin pathway in osteosarcoma were based on cytoplasmic staining of β-catenin or the detection of one component of this pathway. However, those approaches are inappropriate to address whether the Wnt/β-catenin pathway is functionally active. Therefore, in this study, we examined nuclear β-catenin expression in 52 human osteosarcoma biopsies, 15 osteoblastomas (benign bone tumours), and four human osteosarcoma cell lines by immunohistochemistry. Furthermore, we modulated Wnt/β-catenin pathway activity using a GIN (GSK3β inhibitor) and evaluated its effect on cell growth and osteogenic differentiation. Absence of nuclear β-catenin staining was found in 90% of the biopsies and all osteosarcoma cell lines, whereas strong nuclear β-catenin staining was observed in all osteoblastomas. Wnt-luciferase activity was comparable to the negative control in all osteosarcoma cell lines. GIN stimulated the Wnt/β-catenin pathway, as shown by translocation of β-catenin into the nucleus and increased Wnt-luciferase activity as well as mRNA expression of AXIN2, a specific downstream target gene. Stimulation of the Wnt/β-catenin pathway by GIN significantly reduced cell proliferation in the cell lines MG-63 and U-2-OS and enhanced differentiation in the cell lines HOS and SJSA-1, as shown by an increase in alkaline phosphatase (ALP) activity and mineralization. In contrast with the oncogenic role of the Wnt/β-catenin pathway in osteosarcoma as previous studies suggested, here we demonstrate that this pathway is inactivated in osteosarcoma. Moreover, activation of the Wnt/β-catenin pathway inhibits cell proliferation or promotes osteogenic differentiation in osteosarcoma cell lines. Our data suggest that loss of Wnt/β-catenin pathway activity, which is required for osteoblast differentiation, may contribute to osteosarcoma development.
- luci- ferase reporter assay
- Bone tumours
Cai, Y., Mohseny, A. B., Karperien, H. B. J., Hogendoorn, P. C. W., Zhou, G., & Cleton-Jansen, A-M. (2010). Inactive Wnt/β-catenin pathway in conventional high-grade osteosarcoma. Journal of pathology, 220(1), 24-33. https://doi.org/10.1002/path.2628